Allens has advised Anglican Community Services (Anglicare) on its proposed acquisition of aged care provider Infinite Care, announced on 2 March 2026.
The transaction will see Infinite Care become part of Anglicare's residential aged care platform and is expected to create a leading national, for‑purpose aged care provider. It will establish a national platform of approximately 4600 beds across 42 homes in NSW, Queensland, Victoria and South Australia with approximately 7000 staff.
'We are seeing strong transaction activity across retirement living and aged care as investors and operators seek scale, capital certainty and operational resilience,' said co-lead partner Adrian Amer.
'Anglicare's acquisition of Infinite Care reflects the growing strategic importance of high‑quality, mission‑aligned platforms that are well positioned to deliver additional capacity to the market. It also follows a period of heightened deal activity in the sector,' said co-lead partner Victoria Holthouse.
Allens is proud of its relationship with longstanding client Anglicare, having advised it on various real estate, environment and planning, finance and M&A transactions over many years, and on the development of its aged care and affordable housing assets across the Sydney diocese. The firm worked particularly closely with Karen Andersen (Group Executive – Legal, Risk & Governance) and Rocco Musumeci (Head of Legal) on this transaction.
Allens has extensive experience in retirement living and aged care assets. The firm last year advised: Brookfield on its $3.85 billion sale of retirement living provider Aveo to The Living Company, Australia's largest direct real estate transaction; Stonepeak on its investment in Queensland-based retirement village developer and operator Aura Holdings; and Pacific Equity Partners on its acquisition of a circa 50% equity stake in Opal Healthcare, one of Australia's largest privately owned aged care providers.
Canterbury Partners acted as financial advisor to Anglicare and Russell Kennedy assisted on aged care regulatory aspects.
Completion is expected in 1H26 subject to relevant approvals and conditions precedent.
